NASDAQ: REPL · Health Care / Biotechnology: Biological Products (No Diagnostic Substances)

Replimune Group Inc.

How Replimune Group Inc. compares with its industry, its sector and the market: price, value, growth, profit and risk.

Market cap

$1.6B

Price

$17.39

P/E

-6.1

EPS (TTM)

$-2.86

1-year return

70.3%

Dividend yield

0.0%

52-week range

$9.01–$17.39

Compared with

• Biotechnology: Biological Products (No Diagnostic Substances) industry
• Health Care sector

For information only, not investment advice. Data may contain errors. Disclaimer · Sources